Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease　– 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 –-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease　– 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 –

Published:2015 Issue:6 Volume:79 Page:1282-1289
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Shiomi Hiroki¹,Morimoto Takeshi²,Furukawa Yutaka³,Nakagawa Yoshihisa⁴,Sakata Ryuzo⁵,Okabayashi Hitoshi⁶,Hanyu Michiya⁷,Shimamoto Mitsuomi⁸,Nishiwaki Noboru⁹,Komiya Tatsuhiko¹⁰,Kimura Takeshi¹,

Affiliation:

1. Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University

2. Department of Clinical Epidemiology, Hyogo College of Medicine

3. Division of Cardiology, Kobe City Medical Center General Hospital

4. Division of Cardiology, Tenri Hospital

5. Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University

6. Department of Cardiovascular Surgery, Iwate Medical University

7. Division of Cardiovascular Surgery, Kokura Memorial Hospital

8. Division of Cardiovascular Surgery, Shizuoka City Shizuoka Hospital

9. Division of Cardiovascular Surgery, Nara Hospital, Kinki University Faculty of Medicine

10. Division of Cardiovascular Surgery, Kurashiki Central Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/79/6/79_CJ-15-0034/_pdf

Reference23 articles.

1. 1. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961–972.

2. 2. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010; 121: 2645–2653.

3. 3. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008; 358: 1781–1792.

4. 4. Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 2011; 364: 1718–1727.

5. 5. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124: e574–e651, doi:10.1161/CIR.0b013e31823ba622.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can Machine Learning Aid the Selection of Percutaneous vs Surgical Revascularization?;Journal of the American College of Cardiology;2023-11

2. Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive;Canadian Journal of Cardiology;2023-10

3. Post-contrast Acute Kidney Injury After Emergent and Elective Percutaneous Coronary Intervention (from the CREDO-Kyoto PCI/CABG Registry Cohort 3);The American Journal of Cardiology;2023-09

4. Selecting the optimal treatment for left main coronary disease: The importance of identifying subgroups of patients;Journal of Cardiac Surgery;2022-09-28

5. Safety and efficacy of percutaneous coronary intervention versus coronary artery bypass graft in patients with STEMI and unprotected left main stem disease: A systematic review & meta-analysis;IJC Heart & Vasculature;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3